Real-world observational study of current treatment patterns and outcomes in recurrent or locally advanced/metastatic non-small cell lung cancer
Background: Treatment for recurrent or advanced/metastatic non-small cell lung cancer (aNSCLC) has advanced in the past 5 years with immunotherapy (IO).This study sought to describe first-line (1L) aNSCLC treatment patterns and clinical u11-200ps outcomes.Methods: In this retrospective, multisite cohort study, community oncologists reported data fo